Abstract
Summary
LPI (LP Information)' newest research report, the “IVD Raw Materials Industry Forecast” looks at past sales and reviews total world IVD Raw Materials sales in 2022, providing a comprehensive analysis by region and market sector of projected IVD Raw Materials sales for 2023 through 2029. With IVD Raw Materials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Raw Materials industry.
This Insight Report provides a comprehensive analysis of the global IVD Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVD Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IVD Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Raw Materials and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Raw Materials.
The global IVD Raw Materials market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IVD Raw Materials players cover Roche, Life Technologies Corporation (Thermo Fisher), HyTest, Promega, Qiagen, Microbix Biosystems, Fapon Biotech, Bio-Rad and Takara Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Raw Materials market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antigen
Antibody
Diagnostic Enzymes
Others
Segmentation by application
Pharmaceutical Company
Laboratories
Hospitals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Life Technologies Corporation (Thermo Fisher)
HyTest
Promega
Qiagen
Microbix Biosystems
Fapon Biotech
Bio-Rad
Takara Bio
Toyobo Biotech
Nanjing Vazyme Biotech
Nanjing OkayBio
Technopath Clinical Diagnostics
Zoonbio Biotechnology
Rockland Immunochemicals
OYC Europe
SERION Immunologics
VirionSerion GmbH
Prahas Healthcare
Cusabio
Aalto Bio Reagents
Key Questions Addressed in this Report
What is the 10-year outlook for the global IVD Raw Materials market?
What factors are driving IVD Raw Materials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVD Raw Materials market opportunities vary by end market size?
How does IVD Raw Materials break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global IVD Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVD Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global IVD Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Raw Materials and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Raw Materials.
The global IVD Raw Materials market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for IVD Raw Materials is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key IVD Raw Materials players cover Roche, Life Technologies Corporation (Thermo Fisher), HyTest, Promega, Qiagen, Microbix Biosystems, Fapon Biotech, Bio-Rad and Takara Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Raw Materials market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antigen
Antibody
Diagnostic Enzymes
Others
Segmentation by application
Pharmaceutical Company
Laboratories
Hospitals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Life Technologies Corporation (Thermo Fisher)
HyTest
Promega
Qiagen
Microbix Biosystems
Fapon Biotech
Bio-Rad
Takara Bio
Toyobo Biotech
Nanjing Vazyme Biotech
Nanjing OkayBio
Technopath Clinical Diagnostics
Zoonbio Biotechnology
Rockland Immunochemicals
OYC Europe
SERION Immunologics
VirionSerion GmbH
Prahas Healthcare
Cusabio
Aalto Bio Reagents
Key Questions Addressed in this Report
What is the 10-year outlook for the global IVD Raw Materials market?
What factors are driving IVD Raw Materials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVD Raw Materials market opportunities vary by end market size?
How does IVD Raw Materials break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVD Raw Materials Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for IVD Raw Materials by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for IVD Raw Materials by Country/Region, 2018, 2022 & 2029
2.2 IVD Raw Materials Segment by Type
2.2.1 Antigen
2.2.2 Antibody
2.2.3 Diagnostic Enzymes
2.2.4 Others
2.3 IVD Raw Materials Sales by Type
2.3.1 Global IVD Raw Materials Sales Market Share by Type (2018-2023)
2.3.2 Global IVD Raw Materials Revenue and Market Share by Type (2018-2023)
2.3.3 Global IVD Raw Materials Sale Price by Type (2018-2023)
2.4 IVD Raw Materials Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Laboratories
2.4.3 Hospitals
2.4.4 Others
2.5 IVD Raw Materials Sales by Application
2.5.1 Global IVD Raw Materials Sale Market Share by Application (2018-2023)
2.5.2 Global IVD Raw Materials Revenue and Market Share by Application (2018-2023)
2.5.3 Global IVD Raw Materials Sale Price by Application (2018-2023)
3 Global IVD Raw Materials by Company
3.1 Global IVD Raw Materials Breakdown Data by Company
3.1.1 Global IVD Raw Materials Annual Sales by Company (2018-2023)
3.1.2 Global IVD Raw Materials Sales Market Share by Company (2018-2023)
3.2 Global IVD Raw Materials Annual Revenue by Company (2018-2023)
3.2.1 Global IVD Raw Materials Revenue by Company (2018-2023)
3.2.2 Global IVD Raw Materials Revenue Market Share by Company (2018-2023)
3.3 Global IVD Raw Materials Sale Price by Company
3.4 Key Manufacturers IVD Raw Materials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IVD Raw Materials Product Location Distribution
3.4.2 Players IVD Raw Materials Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for IVD Raw Materials by Geographic Region
4.1 World Historic IVD Raw Materials Market Size by Geographic Region (2018-2023)
4.1.1 Global IVD Raw Materials Annual Sales by Geographic Region (2018-2023)
4.1.2 Global IVD Raw Materials Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic IVD Raw Materials Market Size by Country/Region (2018-2023)
4.2.1 Global IVD Raw Materials Annual Sales by Country/Region (2018-2023)
4.2.2 Global IVD Raw Materials Annual Revenue by Country/Region (2018-2023)
4.3 Americas IVD Raw Materials Sales Growth
4.4 APAC IVD Raw Materials Sales Growth
4.5 Europe IVD Raw Materials Sales Growth
4.6 Middle East & Africa IVD Raw Materials Sales Growth
5 Americas
5.1 Americas IVD Raw Materials Sales by Country
5.1.1 Americas IVD Raw Materials Sales by Country (2018-2023)
5.1.2 Americas IVD Raw Materials Revenue by Country (2018-2023)
5.2 Americas IVD Raw Materials Sales by Type
5.3 Americas IVD Raw Materials Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVD Raw Materials Sales by Region
6.1.1 APAC IVD Raw Materials Sales by Region (2018-2023)
6.1.2 APAC IVD Raw Materials Revenue by Region (2018-2023)
6.2 APAC IVD Raw Materials Sales by Type
6.3 APAC IVD Raw Materials Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe IVD Raw Materials by Country
7.1.1 Europe IVD Raw Materials Sales by Country (2018-2023)
7.1.2 Europe IVD Raw Materials Revenue by Country (2018-2023)
7.2 Europe IVD Raw Materials Sales by Type
7.3 Europe IVD Raw Materials Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IVD Raw Materials by Country
8.1.1 Middle East & Africa IVD Raw Materials Sales by Country (2018-2023)
8.1.2 Middle East & Africa IVD Raw Materials Revenue by Country (2018-2023)
8.2 Middle East & Africa IVD Raw Materials Sales by Type
8.3 Middle East & Africa IVD Raw Materials Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IVD Raw Materials
10.3 Manufacturing Process Analysis of IVD Raw Materials
10.4 Industry Chain Structure of IVD Raw Materials
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IVD Raw Materials Distributors
11.3 IVD Raw Materials Customer
12 World Forecast Review for IVD Raw Materials by Geographic Region
12.1 Global IVD Raw Materials Market Size Forecast by Region
12.1.1 Global IVD Raw Materials Forecast by Region (2024-2029)
12.1.2 Global IVD Raw Materials Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IVD Raw Materials Forecast by Type
12.7 Global IVD Raw Materials Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche IVD Raw Materials Product Portfolios and Specifications
13.1.3 Roche IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Life Technologies Corporation (Thermo Fisher)
13.2.1 Life Technologies Corporation (Thermo Fisher) Company Information
13.2.2 Life Technologies Corporation (Thermo Fisher) IVD Raw Materials Product Portfolios and Specifications
13.2.3 Life Technologies Corporation (Thermo Fisher) IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Life Technologies Corporation (Thermo Fisher) Main Business Overview
13.2.5 Life Technologies Corporation (Thermo Fisher) Latest Developments
13.3 HyTest
13.3.1 HyTest Company Information
13.3.2 HyTest IVD Raw Materials Product Portfolios and Specifications
13.3.3 HyTest IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 HyTest Main Business Overview
13.3.5 HyTest Latest Developments
13.4 Promega
13.4.1 Promega Company Information
13.4.2 Promega IVD Raw Materials Product Portfolios and Specifications
13.4.3 Promega IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Promega Main Business Overview
13.4.5 Promega Latest Developments
13.5 Qiagen
13.5.1 Qiagen Company Information
13.5.2 Qiagen IVD Raw Materials Product Portfolios and Specifications
13.5.3 Qiagen IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Qiagen Main Business Overview
13.5.5 Qiagen Latest Developments
13.6 Microbix Biosystems
13.6.1 Microbix Biosystems Company Information
13.6.2 Microbix Biosystems IVD Raw Materials Product Portfolios and Specifications
13.6.3 Microbix Biosystems IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Microbix Biosystems Main Business Overview
13.6.5 Microbix Biosystems Latest Developments
13.7 Fapon Biotech
13.7.1 Fapon Biotech Company Information
13.7.2 Fapon Biotech IVD Raw Materials Product Portfolios and Specifications
13.7.3 Fapon Biotech IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fapon Biotech Main Business Overview
13.7.5 Fapon Biotech Latest Developments
13.8 Bio-Rad
13.8.1 Bio-Rad Company Information
13.8.2 Bio-Rad IVD Raw Materials Product Portfolios and Specifications
13.8.3 Bio-Rad IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio-Rad Main Business Overview
13.8.5 Bio-Rad Latest Developments
13.9 Takara Bio
13.9.1 Takara Bio Company Information
13.9.2 Takara Bio IVD Raw Materials Product Portfolios and Specifications
13.9.3 Takara Bio IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Takara Bio Main Business Overview
13.9.5 Takara Bio Latest Developments
13.10 Toyobo Biotech
13.10.1 Toyobo Biotech Company Information
13.10.2 Toyobo Biotech IVD Raw Materials Product Portfolios and Specifications
13.10.3 Toyobo Biotech IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Toyobo Biotech Main Business Overview
13.10.5 Toyobo Biotech Latest Developments
13.11 Nanjing Vazyme Biotech
13.11.1 Nanjing Vazyme Biotech Company Information
13.11.2 Nanjing Vazyme Biotech IVD Raw Materials Product Portfolios and Specifications
13.11.3 Nanjing Vazyme Biotech IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Nanjing Vazyme Biotech Main Business Overview
13.11.5 Nanjing Vazyme Biotech Latest Developments
13.12 Nanjing OkayBio
13.12.1 Nanjing OkayBio Company Information
13.12.2 Nanjing OkayBio IVD Raw Materials Product Portfolios and Specifications
13.12.3 Nanjing OkayBio IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nanjing OkayBio Main Business Overview
13.12.5 Nanjing OkayBio Latest Developments
13.13 Technopath Clinical Diagnostics
13.13.1 Technopath Clinical Diagnostics Company Information
13.13.2 Technopath Clinical Diagnostics IVD Raw Materials Product Portfolios and Specifications
13.13.3 Technopath Clinical Diagnostics IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Technopath Clinical Diagnostics Main Business Overview
13.13.5 Technopath Clinical Diagnostics Latest Developments
13.14 Zoonbio Biotechnology
13.14.1 Zoonbio Biotechnology Company Information
13.14.2 Zoonbio Biotechnology IVD Raw Materials Product Portfolios and Specifications
13.14.3 Zoonbio Biotechnology IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zoonbio Biotechnology Main Business Overview
13.14.5 Zoonbio Biotechnology Latest Developments
13.15 Rockland Immunochemicals
13.15.1 Rockland Immunochemicals Company Information
13.15.2 Rockland Immunochemicals IVD Raw Materials Product Portfolios and Specifications
13.15.3 Rockland Immunochemicals IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Rockland Immunochemicals Main Business Overview
13.15.5 Rockland Immunochemicals Latest Developments
13.16 OYC Europe
13.16.1 OYC Europe Company Information
13.16.2 OYC Europe IVD Raw Materials Product Portfolios and Specifications
13.16.3 OYC Europe IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 OYC Europe Main Business Overview
13.16.5 OYC Europe Latest Developments
13.17 SERION Immunologics
13.17.1 SERION Immunologics Company Information
13.17.2 SERION Immunologics IVD Raw Materials Product Portfolios and Specifications
13.17.3 SERION Immunologics IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 SERION Immunologics Main Business Overview
13.17.5 SERION Immunologics Latest Developments
13.18 VirionSerion GmbH
13.18.1 VirionSerion GmbH Company Information
13.18.2 VirionSerion GmbH IVD Raw Materials Product Portfolios and Specifications
13.18.3 VirionSerion GmbH IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 VirionSerion GmbH Main Business Overview
13.18.5 VirionSerion GmbH Latest Developments
13.19 Prahas Healthcare
13.19.1 Prahas Healthcare Company Information
13.19.2 Prahas Healthcare IVD Raw Materials Product Portfolios and Specifications
13.19.3 Prahas Healthcare IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Prahas Healthcare Main Business Overview
13.19.5 Prahas Healthcare Latest Developments
13.20 Cusabio
13.20.1 Cusabio Company Information
13.20.2 Cusabio IVD Raw Materials Product Portfolios and Specifications
13.20.3 Cusabio IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Cusabio Main Business Overview
13.20.5 Cusabio Latest Developments
13.21 Aalto Bio Reagents
13.21.1 Aalto Bio Reagents Company Information
13.21.2 Aalto Bio Reagents IVD Raw Materials Product Portfolios and Specifications
13.21.3 Aalto Bio Reagents IVD Raw Materials Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Aalto Bio Reagents Main Business Overview
13.21.5 Aalto Bio Reagents Latest Developments
14 Research Findings and Conclusion